Research Article

Epidemiologic Characteristics of Adolescents with COVID-19 Disease with Acute Hypoxemic Respiratory Failure

Table 3

Selected laboratory characteristics of hospitalized patients.

CharacteristicsTotal (n = 47)

WBC, k/µL, median (IQR) (n = 47)9.8 (7.5–13.7)
Hemoglobin, g/dL, median (IQR) (n = 47)13.3 (12.1–14.6)
Platelets, k/µL, median (IQR) (n = 47)270 (230–354)
AST, U/L, median (IQR) (n = 47)24 (18.25–34.75)
ALT, U/L, median (IQR) (n = 47)18.5 (10.5–27.75)
Total bilirubin, mg/dL, median (IQR) (n = 47)0.45 (0.4–0.7)
BUN, mg/dL, median (IQR) (n = 47)10 (7–11)
Creatinine, mg/dL, median (IQR) (n = 47]0.62 (0.38–0.81)
C-reactive protein, mg/dL, median (IQR) (n = 18)43.75 (5.85–189.05)
Procalcitonin, ng/mL, median (IQR) (n = 10)0.125 (0.0575–4.67)
Pro-BNP, pg/mL, median (IQR) (n = 9)54 (19–396)
Troponin, ng/mL, median (IQR) (n = 13)0.011 (0.01–0.048)
CPK, U/L, median (IQR) (n = 11)62.5 (27.25–225.75)
Lactate, mmol/L, median (IQR) (n = 13)1 (0.9–2.2)
D-dimer, µg/mL FEU, median (IQR) (n = 17)1.48 (0.6525–3.01)
LDH, U/L, median (IQR) (n = 17)279 (157.25–341)
IL-6, pg/mL, median (IQR) (n = 2)84.25 (45.325–123.175)